Is Quant’s Life Hard or Easy?

Follow us on LinkedIn

Last month, efinancialcarreeers published a post, stating that quant’s life is getting harder these days.

Back in the day, a quant in finance could devise a strategy, sit back and let the money roll in while lounging about in a silk robe with a fat cigar. Such are the halcyon dreams of the contemporary quantitative finance type who finds him/herself forced to grind continuously in front of a screen in search of illusory alpha while every man/woman with a piece of Python code does the same.

This wasn’t the exact complaint at today’s Quant Conference (held digitally this year), but it came close. Read more

My life as a quant

A week later, they published another post. This time it told the story of a former hedge fund IT professional who is trying to commoditize the systematic trading software market.

Our mission is to commoditize high-performance systematic trading software,” says Bogdan Donca. “This software is built over and over by both the buy-side and the sell-side and it has a high degree of reuse. We’ve created an off-the-shelf product for systematic hedge funds.”

… He says software is a factor in alpha generation. “Your success as a systematic hedge fund is partly about how quickly you can iterate trading strategy ideas. There is no Holy Grail and there is no single strategy – it’s about iteration and deploying test strategies and this requires software engineering excellence.” Read more

The latter article implies that big hedge funds and investment banks still have an edge by using software and data, and that quant’s life is still easy.

Don’t you think that these 2 articles are contradictory?

So is quant’s life hard or easy?

Let us know your opinion.

Further questions

What's your question? Ask it in the discussion forum

Have an answer to the questions below? Post it here or in the forum

LATEST NEWSGoldman Sachs reports earnings before market open — here's what the Street expects
Goldman Sachs reports earnings before market open — here's what the Street expects

Goldman Sachs CEO David Solomon has taken his lumps in the past year, but hope is building for a turnaround.

Stay up-to-date with the latest news - click here
LATEST NEWSXali Gold Signs New Agreement for Sale of the El Oro Tailings Project
Xali Gold Signs New Agreement for Sale of the El Oro Tailings Project

VANCOUVER, British Columbia, April 15, 2024 (GLOBE NEWSWIRE) — Xali Gold Corp. (TSXV:XGC) (“Xali Gold” or the “Company”) is pleased to announce that the Company has signed a Letter of Intent to enter a Purchase Agreement (the “LOI Agreement”) with Kappes, Cassiday & Associates (“KCA”)…

Stay up-to-date with the latest news - click here
LATEST NEWSTalisker Samples Up to 97.7 g/t Au at the Ladner Gold Project
Talisker Samples Up to 97.7 g/t Au at the Ladner Gold Project

TORONTO, April 15, 2024 (GLOBE NEWSWIRE) — Talisker Resources Ltd. (“Talisker” or the “Company”) (TSX:TSK | OTCQX:TSKFF) is pleased to announce results from its summer 2023 mapping and surface sampling campaign at the Ladner Gold Project. A total of 175 rock samples were collected between…

Stay up-to-date with the latest news - click here
LATEST NEWSAxsome Therapeutics Highlights Innovative Neuroscience Portfolio at the American Academy of Neurology (AAN) 2024 Annual Meeting
Axsome Therapeutics Highlights Innovative Neuroscience Portfolio at the American Academy of Neurology (AAN) 2024 Annual Meeting

AXS-05 in Alzheimer’s disease agitation data featured in oral plenary session New data for AXS-07 in migraine demonstrating efficacy in pooled analysis Presentations on cognitive and wake promoting effects of solriamfetol NEW YORK, April 15, 2024 (GLOBE NEWSWIRE) — Axsome Therapeutics, Inc. (NASDAQ: AXSM), a…

Stay up-to-date with the latest news - click here
LATEST NEWSCannMart Marks International Debut with First Shipment of Cannabis Products to Australia
CannMart Marks International Debut with First Shipment of Cannabis Products to Australia

TORONTO, April 15, 2024 (GLOBE NEWSWIRE) — Lifeist Wellness Inc. (“Lifeist” or the “Company”) (TSXV: LFST) (FRANKFURT: M5B) (OTCMKTS: LFSWF), a health-tech company that leverages advancements in science and technology to build breakthrough ventures that transform human wellness, today announced that its subsidiary CannMart Inc.…

Stay up-to-date with the latest news - click here

Leave a Reply